ERBB2 and ovarian cancer: In the translational setting, PD-L1 NIR-PIT could be applied intraoperatively during debulking of ovarian cancer or using an endoscopic approach to target peritoneally disseminated disease, as shown in a model of Her2+ gastric carcinoma [8].